The effect of therapeutic lumbar punctures on acute mortality from cryptococcal meningitis. - Wikidata - awgldk - TriplyDB

The effect of therapeutic lumbar punctures on acute mortality from cryptococcal meningitis.

The effect of therapeutic lumbar punctures on acute mortality from cryptococcal meningitis.

http://www.wikidata.org/entity/Q35635476

about

Integrated therapy for HIV and cryptococcosis HIV-Associated Cryptococcal Meningitis: Bridging the Gap Between Developed and Resource-Limited Settings Cryptococcal meningitis: A neglected NTD?Cryptococcosis diagnosis and treatment: What do we know now Evaluation of fingerstick cryptococcal antigen lateral flow assay in HIV-infected persons: a diagnostic accuracy study.Cryptococcal Meningitis: Diagnosis and Management Update.Prevalence and Hospital Management of Amphotericin B Deoxycholate-Related Toxicities during Treatment of HIV-Associated Cryptococcal Meningitis in South Africa Factors associated with early mycological clearance in HIV-associated cryptococcal meningitis Cytokine patterns in a prospective cohort of HIV-infected patients with cryptococcal meningitis following initiation of antifungal and antiretroviral therapy Reversible Deafness and Blindness in a Patient with Cryptococcal Meningitis in Tanzania CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).Recent advances in AIDS-related cryptococcal meningitis treatment with an emphasis on resource limited settings.Cryptococcal Disease in HIV-Infected Children.Lumbar puncture refusal in sub-Saharan Africa: A call for further understanding and intervention Opportunistic Invasive Mycoses in AIDS: Cryptococcosis, Histoplasmosis, Coccidiodomycosis, and Talaromycosis.Short-Course Induction Treatment with Intrathecal Amphotericin B Lipid Emulsion for HIV Infected Patients with Cryptococcal Meningitis.Inadequacy of High-Dose Fluconazole Monotherapy Among Cerebrospinal Fluid Cryptococcal Antigen (CrAg)-Positive Human Immunodeficiency Virus-Infected Persons in an Ethiopian CrAg Screening Program.Cryptococcosis today: It is not all about HIV infection.Central Nervous System Infections Associated with Immunosuppressive Therapy for Rheumatic Disease.HIV-Associated Cryptococcal Disease in Resource-Limited Settings: A Case for "Prevention Is Better Than Cure"?Colliding Epidemics and the Rise of Cryptococcosis.Global HIV neurology: a comprehensive review.Cryptococcosis.The war on cryptococcosis: A Review of the antifungal arsenal.Diagnostic and therapeutic strategies in cryptococcosis: impact on outcome.Population Pharmacokinetic Model and Meta-analysis of Outcomes of Amphotericin B Deoxycholate Use in Adults with Cryptococcal Meningitis.A qualitative evaluation of an implementation study for cryptococcal antigen screening and treatment in Uganda Cerebral Oximetry for Detecting High-mortality Risk Patients with Cryptococcal Meningitis Present and Future Therapy of Infections

P2860

Q28077707-2C16498B-FC20-4045-897D-02A73E28C539 Q28078958-D9AACDBB-6B10-4BAE-A511-E7DFD9459E05 Q33852819-3FD81B8C-7120-4DDE-8E02-71B79710A842 Q35395169-5C169349-5F01-43BA-8AB0-972E94B874FE Q35855950-48FF5BF0-CFD4-46B0-A130-16393EE4780F Q35951094-A0858A8E-8E31-408E-B253-83994EB1806D Q36088679-B416261D-1EF9-4C0C-A737-B8CBA61666A8 Q36326762-1BB75F49-D899-487F-8FF9-D15BE15B1C0D Q36366992-414AD136-C723-4BA8-8EA0-16FFFAF72B49 Q36409728-0D80B424-C2D0-4B85-AAC1-DAA0FCEE7A6F Q37041199-94A424A0-DA99-4171-9613-476721884717 Q38851467-4B360326-083A-4364-8EA3-57AE503C1BFB Q38904619-08A2CFBF-4933-4816-AF5B-3020D25424F6 Q39519314-4352B249-34B3-4AAC-9ABA-FB6D9AA85883 Q40074359-13F93D7F-7E2E-4DD0-ADB9-128B10779311 Q40961271-1DA3A038-8E37-42FC-ADC6-DA88BF706E1D Q45326483-7C93EC02-4867-4445-8B26-066AD77C03B5 Q46262999-BA241877-7A96-47B1-A1C2-4087229D6704 Q46339578-866820D8-400B-4C6D-B58C-A410A779DF9C Q47646979-0999EAE6-E97C-4A33-8540-D897921D3A2A Q49287757-12B7FE75-980F-4F9F-9B7D-ADA313048986 Q51762497-E16328B4-92E5-49C2-9182-E3B0CE763C48 Q51818572-ED06BE97-3170-48BE-A066-17AA1FF6F470 Q54260674-A1435D81-796C-4C43-B1E8-B37F624C1630 Q55229762-0E53FC03-1699-4E5E-B2A2-28569A25C217 Q55488494-6FBE679A-FB3D-4CAC-8939-304C3AF7EE8C Q56910972-774C4E12-3085-44AE-8E5B-1A50F8A3FC84 Q56912245-AF29E496-D33D-44DF-91B2-D8FC355999AB Q57177336-53679680-9D66-4E91-848E-BA02E5E10E27

P2860

The effect of therapeutic lumbar punctures on acute mortality from cryptococcal meningitis.

http://www.wikidata.org/entity/Q35635476

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

The effect of therapeutic lumb ...... from cryptococcal meningitis.

@ast

The effect of therapeutic lumb ...... from cryptococcal meningitis.

@en

type

label

The effect of therapeutic lumb ...... from cryptococcal meningitis.

@ast

The effect of therapeutic lumb ...... from cryptococcal meningitis.

@en

prefLabel

The effect of therapeutic lumb ...... from cryptococcal meningitis.

@ast

The effect of therapeutic lumb ...... from cryptococcal meningitis.

@en

P1433

Q35635476-6F112C9D-F5A2-4307-A25B-FC074C567845

P1476

Q35635476-2447D739-2840-4F87-A5BF-3F3BCB804DE9

P2093

Q35635476-01C827A7-FD44-442C-A565-4D9CE8837EBC

Q35635476-2399E152-55FA-439C-B47A-4E969ED660D7

Q35635476-31CFC3CB-B4FB-4F2B-ABA6-A157444CE42D

Q35635476-40A03B5F-0C26-4356-9782-3885BEA365E8

Q35635476-627A8276-D2A0-4321-AB66-B7C0104ECC53

Q35635476-6FC7BF54-795F-4F23-9299-07CF5C10C421

Q35635476-88D22A27-55FD-4C1C-9DA0-7587B563E9CF

Q35635476-8ED37677-B397-47ED-9DFC-5EAA95617B69

Q35635476-F5705174-AC92-4C84-9F03-ADD8217F7768

P2860

Q35635476-06A5D891-EB13-4F03-B244-6EC5D1B93B42

Q35635476-1056DC67-FAB9-4AD5-AC24-7656EF3D371A

Q35635476-149ADF9A-075F-46FA-A0D3-33DD27D015A6

Q35635476-17D60DC2-D288-48A7-9E75-086CCC4DF16A

Q35635476-3349032A-2B68-492A-9A75-57BC64292D9C

Q35635476-5FAAA61A-EFDC-44D1-9974-F28EA649284C

Q35635476-66BA38EE-AA57-4428-8E29-96D1BD00C6F5

Q35635476-6CF8AE03-13D6-4840-8CBD-50BA6E78C331

Q35635476-6FF1CFC4-6E5A-4C4E-A4F4-38D7E298C2D6

Q35635476-7AC93409-BFB7-4035-B4A3-6674B20D7253

P304

Q35635476-505F97D4-0EBD-47B1-B678-EAD29FA219E8

P31

Q35635476-5F3109FB-DCFB-4417-88BD-718897F8AFE0

P356

Q35635476-C9EAFD7C-6B44-4AD4-8CB7-625AE4E00186

P407

Q35635476-3B97E9A6-B0E2-4449-98CF-227BF9A72757

P433

Q35635476-C6859DDA-FB01-4763-8FCE-B217CB91E475

P478

Q35635476-4401AD7C-81E2-451A-B7FA-AC38338B1A4A

P50

Q35635476-30A3A438-166A-4415-96F1-D4738695C2DD

Q35635476-3731A6CD-186C-4F65-9FEB-BCA3FDD0BC99

Q35635476-5C05609F-562C-4A79-A2B7-E0C7DD40E7DE

Q35635476-B0D04FF7-755D-4D58-B868-06798F8FF17A

Q35635476-D9332E62-9E5C-4E77-91C2-8EF4EFD8F6FF

P577

Q35635476-71F3E33B-579E-4CA9-9833-FF0A5931E20C

P5875

Q35635476-2CDBC5D9-ED0E-483C-8DBE-1E1AE259E9BE

P698

Q35635476-ACA03DEE-26D2-4BE9-8AB4-0AA3ECB29C89

P921

Q35635476-49A17F23-A2E5-4A99-B178-8C294C619E0A

P932

Q35635476-282AF22F-9B7B-4EC6-A2D5-94507C0CB920

P356

P1433

Clinical Infectious Diseases

P1476

The effect of therapeutic lumb ...... from cryptococcal meningitis.

@en

P2093

Abdu Musubire

http://www.w3.org/2001/XMLSchema#string

Conrad Muzoora

http://www.w3.org/2001/XMLSchema#string

Darlisha A Williams

http://www.w3.org/2001/XMLSchema#string

David B Meya

http://www.w3.org/2001/XMLSchema#string

Henry W Nabeta

http://www.w3.org/2001/XMLSchema#string

Kabanda Taseera

http://www.w3.org/2001/XMLSchema#string

Kathy Huppler Hullsiek

http://www.w3.org/2001/XMLSchema#string

Melissa A Rolfes

http://www.w3.org/2001/XMLSchema#string

Radha Rajasingham

http://www.w3.org/2001/XMLSchema#string

P2860

Outcome of AIDS-associated cryptococcal meningitis initially treated with 200 mg/day or 400 mg/day of fluconazole

Clinical presentation, natural history, and cumulative death rates of 230 adults with primary cryptococcal meningitis in Zambian AIDS patients treated under local conditions

A modified poisson regression approach to prospective studies with binary data

Low CD4 count plus coma predicts cryptococcal meningitis in Tanzania

Symptomatic relapse of HIV-associated cryptococcal meningitis in South Africa: the role of inadequate secondary prophylaxis

Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

Population-based surveillance for cryptococcosis in an antiretroviral-naive South African province with a high HIV seroprevalence.

Histopathology of the arachnoid granulations and brain in HIV-associated cryptococcal meningitis: correlation with cerebrospinal fluid pressure.

Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy.

P304

1607-1614

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CID/CIU596

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P50

David R. Boulware

Charlotte Schutz

Graeme Meintjes

Friedrich Thienemann

P577

2014-07-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264202120

http://www.w3.org/2001/XMLSchema#string

P698

25057102

http://www.w3.org/2001/XMLSchema#string

P921

P932

4441057

http://www.w3.org/2001/XMLSchema#string